VILAS PATWARDHAN: Open Payments
NPI 1043479587 · BOSTON, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,205 in 3 payments from 1 company in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $2,205
Consulting: $2,040Food & beverage: $165
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 3 | $2,205 |
Products named: Livdelzi.
Industry payments across MA — which companies pay providers there.
